CARL ZEISS MEDITECCARL ZEISS MEDITECCARL ZEISS MEDITEC

CARL ZEISS MEDITEC

No trades
See on Supercharts
Market capitalization
‪8.85 B‬CHF
‪281.04 M‬CHF
‪2.02 B‬CHF
‪36.55 M‬
Beta (1Y)
1.15

About CARL ZEISS MEDITEC

CEO
Markus Weber
Website
Headquarters
Jena
Employees (FY)
‪4.82 K‬
Founded
1995
ISIN
DE0005313704
FIGI
BBG006TLNMB2
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Strategic Business Unit (SBU) and Microsurgery business SBU segments. The Ophthalmic SBU segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery SBU segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded in 2002 and is headquartered in Jena, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AFX is 94.40 CHF — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange CARL ZEISS MEDITEC stocks are traded under the ticker AFX.
CARL ZEISS MEDITEC is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
AFX stock is 0% volatile and has beta coefficient of 1.15. Check out the list of the most volatile stocks — is CARL ZEISS MEDITEC there?
One year price forecast for CARL ZEISS MEDITEC has a max estimate of 145.45 CHF and a min estimate of 67.85 CHF.
Yes, you can track CARL ZEISS MEDITEC financials in yearly and quarterly reports right on TradingView.
AFX net income for the last quarter is ‪171.63 M‬ CHF, while the quarter before that showed ‪112.17 M‬ CHF of net income which accounts for 53.01% change. Track more CARL ZEISS MEDITEC financial stats to get the full picture.
Today CARL ZEISS MEDITEC has the market capitalization of ‪8.40 B‬, it has increased by 4.28% over the last week.
Yes, AFX dividends are paid annually. The last dividend per share was 1.07 CHF. As of today, Dividend Yield (TTM)% is 1.14%. Tracking CARL ZEISS MEDITEC dividends might help you take more informed decisions.
CARL ZEISS MEDITEC dividend yield was 1.33% in 2023, and payout ratio reached 33.88%. The year before the numbers were 1.02% and 33.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AFX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARL ZEISS MEDITEC stock right from TradingView charts — choose your broker and connect to your account.
AFX reached its all-time high on May 31, 2019 with the price of 99.80 CHF, and its all-time low was 22.75 CHF and was reached on Jan 16, 2015.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪4.82 K‬ employees. See our rating of the largest employees — is CARL ZEISS MEDITEC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARL ZEISS MEDITEC technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARL ZEISS MEDITEC stock shows the buy signal. See more of CARL ZEISS MEDITEC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CARL ZEISS MEDITEC future price: according to them, AFX price has a max estimate of 145.44 CHF and a min estimate of 67.87 CHF. Read a more detailed CARL ZEISS MEDITEC forecast: see what analysts think of CARL ZEISS MEDITEC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARL ZEISS MEDITEC EBITDA is ‪412.75 M‬ CHF, and current EBITDA margin is 20.92%. See more stats in CARL ZEISS MEDITEC financial statements.